Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
BMJ Oncology|April 1, 2026
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trialsJ Randolph Hecht, Julian R Molina, Kirstin Liechty, et al.
BMJ Oncology|April 13, 2026
Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messagingSaeid Shahraz, On Yee Wong, Rina Chotai, et al.
BMJ Oncology|April 13, 2026
Incident anaemia as a marker of cancer and all-cause mortality: evidence from 380 114 adults in the population-based Stockholm Early Detection of Cancer Study (STEADY-CAN) cohortElinor Nemlander, Eliya Abedi, Jan Hasselström, et al.
BMJ Oncology|September 3, 2026
Aligning awareness, systems and policy to increase equitable access to genomically driven cancer careKelly Kohut, Joshua Asaad Kuti, Sandra Balladares, et al.
BMJ Oncology|July 22, 2026
Identification and management of genetic susceptibility to cancer: UK perspectiveCiaran McCarthy, Katie Snape
BMJ Oncology|September 11, 2026
Ipsilateral recurrences after kidney-sparing surgery for upper tract urothelial carcinoma: a systematic review and meta-analysisElin Ståhl, Sanjib Saha, Johannes Bobjer, et al.
BMJ Oncology|June 13, 2025
Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomicsAnders Handrup Kverneland, Ole Østergaard, Joel Emanuel Sohlin, et al.
BMJ Oncology|June 13, 2025
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023)Neil Ryan, Kane Alexander Lennie, Adam Naskretski, et al.
BMJ Oncology|April 8, 2025
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expressionSara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, et al.
BMJ Oncology|May 13, 2025
Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trialsEduardo Urias, Jaehoon Lee, Christopher R Weil, et al.
Pageof 17